The rise of GLP-1 drugs is a reminder that we must move beyond the simple equation of thinness as health and value. These ...

Connecticut passed a new law last week in an effort to lower its spending on weight-loss drugs for its state insurance program — HUSKY Health, which includes Medicaid and CHIP enrollees — and it could ...

A population-based cohort study emulating a target trial estimated the effect of glucagon-like peptide-1 receptor agonists ...

Explore "The Ozempic Revolution" by Dr Alexandra Sowa—a guide to weight-loss drugs like Ozempic, their benefits, side effects ...

With their lengthening laundry list of health benefits, drugs like Ozempic and Wegovy are showing promise outside of weight ...

GLP-1RA users had a 37% lower risk of developing dementia compared to those on other antidiabetic drugs. Stroke risk reduced ...

Modern weight loss medications represent a breakthrough, but they are most effective when combined with the right lifestyle strategies. Here's what that looks like.

Omada Health (OMDA) is a strong buy. Backed by 29 studies, key partnerships with Cigna and CVS drive growth, credibility, and ...

Newsweek spoke to some experts about whether the weight loss drug could have an impact on birth rates in America.

Its total income stood at ₹5,189 crore during the June 2025 quarter, up from ₹4,278 crore in the same period a year ago ...

Novo shares are a bargain, trading at 18 times earnings estimates. The catch is it's a wobbly time to invest – in May, the ...

Olympic coach Dane Miller joins Power Athlete Radio to unpack elite training, performance drugs, the science of gut health, and the explosive rise of women’s athletics in a raw, unfiltered ...